Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients

International Journal of Cancer

Volumn 92, Issue 1, 2001, Pages 79-87

  Staib, Ludger ^a   Birebent, Brigitte ^b   Somasundaram, Rajasekharan ^b   Purev, Enkhtsetseg ^b   Braumüller, Heidi ^b   Leeser, Christian ^a   Küttner, Norbert ^a,b   Li, Weiping ^a   Zhu, Dawei ^a   Diao, Jun ^a   Wunner, William ^b   Speicher, David ^b   Beger, Hans Günther ^a   Song, Hong ^b   Herlyn, Dorothee ^b  

^a UNIVERSITY OF ULM   (Germany)

^b WISTAR INSTITUTE   (United States)

Author keywords

GA733 2E antigen; Gastro intestinal carcinoma; Immune response; Pancreatic carcinoma; Vaccine

Indexed keywords

CO 17 1A; EGP; EPITHELIAL CELL ADHESION MOLECULE; EPITOPE; GA 733 2E; KS 1-4; KSA; MONOCLONAL ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; PANCREAS CARCINOMA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0035313990     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1164>3.0.CO;2-J     Document Type: Article

References (35)

1. Clinical implications of the new biology in the development of melanoma vaccines
2. Biological therapy: Approaches in colorectal cancer
3. Efficient selection of human tumor growth-inhibiting monoclonal antibodies
4. Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies
5. Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody
6. Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA
7. Ep-CAM: A human epithelial antigen is a hemophilic cell-cell adhesion molecule
8. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
9. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
10. Anti-idiotype immunization of cancer patients: Modulation of the immune response
11. Immunoreactivity of a patient with colorectal cancer metastasis after immunization with anti-idiotypes
12. Anti-idiotype cancer vaccines: Pre-clinical and clinical studies
13. Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody
14. Induction of antigen-specific T and B cell immunity in colon carcinoma patients by anti-idiotypic antibody
15. Immunoregulatory activity of monoclonal anti-idiotypic anti-body to anti-colorectal carcinoma antibody CO17-1A in animals and patients
16. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2
17. Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen
18. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoctonal antibodies
19. Ex vivo perfusion of a tumor-containing colon with monoclonal antibody
20. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma
21. Production and characterization of monoclonal antibodies against malignant melanoma
22. Cytotoxic T cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells
23. Expression of an antigen homologous to the human CO17-1A/ GA733 colon cancer antigen in animal tissues
24. Induction of immunity to colon carcinoma antigen CO17-1A by monoclonal anti-idiotype (Ab2): Effects of Ab2 fragmentation, carrier and adjuvant
25. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen. NCA, in human sera
26. Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines
27. Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients
28. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid
29. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUCI mucin
30. Screening of anti-MUCI antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUCI and for blocking MUCI specific cytotoxic T-lymphocytes
31. Autoantibodies against the tumor-associated antigen GA733-2 in patients with colorectal carcinoma
32. Cancer: p53, guardian of the genotue
33. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
34. Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice
35. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for tine induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen